Abstract:Purpose Esophageal cancer is the most common gastrointestinal tumor and is difficult to be eradicated with conventional treatment. Porphyrin-based photosensitizers (PSs) mediated photodynamic therapy (PDT) could kill tumor cells with less damage to normal cells. As the most widely used porphyrin-based photosensitizer in clinics, Photofrin II has excellent anti-tumor effect. However, it has some disadvantages such as weak absorption at near infrared region, the complexity of components and prolonged skin photosensitivity. Here series novel 5,15-diaryl-10,20-dihalogeno porphyrin derivatives were afforded and evaluated to develop more effective and safer photosensitizers for tumor therapy. Methods The photophysical properties and singlet oxygen generation rates of 5,15-diaryl-10,20-dihalogeno porphyrins ( I 1-6 , II 1-4 ) were tested. The cytotoxicity of I 1-6 and II 1-4 were measured by MTT assay. The pathway of cell death was studied by flow cytometry. In vivo photodynamic efficacy of I 3 and II 2-4 in Eca-109 tumor-bearing BABL/c nude mice were measured and histopathological analysis were examined. Results 5,15-Diaryl-10,20-dihalogeno porphyrins I 1-6 and II 1-4 were synthesized. The longest absorption wavelength of these halogenated porphyrins ( λ max = 660 nm) displayed a red shift around 30 nm compared to the unhalogenated porphyrins PS 1 ( λ max = 630 nm). The singlet oxygen generation rates of I 1-6 and II 1-4 were significantly higher than PS 1 and HMME. All PSs mediated PDT showed obvious cytotoxic effect against Eca-109 cells compared to HMME in vitro and in vivo. Among these PSs, II 4 exhibited appropriate absorption in the phototherapeutic window, higher 1 O 2 generation rate ( k = 0.0061 s −1 ), the strongest phototoxicity (IC 50 = 0.4 μM), lower dark toxicity, high generation of intracellular ROS in Eca-109 cells and excellent photodynamic anti-tumor efficacy in vivo. Besides, cell necrosis was induced by compound II 4 mediated PDT. Conclusion All new compounds have obvious photodynamic anti-esophageal cancer effects. Among them, the photosensitizer II 4 showed excellent efficacy in vitro and in vivo, which has the potential to become a photodynamic anti-tumor drug.

Synthesis and Tumor-Photobiological Activities of 2-(1-hydroxyl)ethyl Chlorin F and Its Ether Derivatives

Synthesis and evaluation of new fluorinated pyropheophorbide-a derivatives for photodynamic therapy

Synthesis and evaluation of novel fluorinated hematoporphyrin ether derivatives for photodynamic therapy

Syntheses of BODIPY photosensitizers and their photodynamic effect on tumor cells

Photodynamic Effect Of Chlorophyll Derivative With Pulsed Copper Vapor Laser On Human Rectal-Carcinoma Invitro

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

POTENTIAL PHOTOSENSITIZERS FOR PHOTODYNAMIC TUMOR THERAPY—I. PHOTOPHYSICAL PROPERTIES OF TWO CHLORIN DERIVATIVES

Novel pyropheophorbide a dimers: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy

Synthesis and evaluation of novel meso -substitutedphenyl dithieno[3,2-b]thiophene-fused BODIPY derivatives as efficient photosensitizers for photodynamic therapy

Design, synthesis, antitumor activity and ct-DNA binding study of photosensitive drugs based on porphyrin framework

Particle swarm optimization and genetic algorithm as feature selection techniques for the QSAR modeling of imidazo[1,5‐a]pyrido[3,2‐e]pyrazines, inhibitors of phosphodiesterase 10A

Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation

[Synthesis of BODIPY Photosensitizers and Their Photodynamic Effect on Cancer Cells].

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives

Synthesis of Novel 3-(Substituted Phenyl) Chromone Derivatives and Their Anti-Tumor Activities

Novel chlorin e 6 -based conjugates of tyrosine kinase inhibitors: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy